Bone Sialoprotein Promotes Tumor Cell Migration in Both In Vitro and In Vivo Models

References

• Yoneda, T. (1998). Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur. J. Cancer 34:240–245.
   PubMed Web of Science ®Google Scholar
• Oldberg, A., Franzen, A., and Heinegard D. (1988). The primary structure of a cell-binding bone sialoprotein. J. Biol. Chem. 263:19430–19432.
   PubMed Web of Science ®Google Scholar
• Chen, J., Shapiro, H.S., and Sodek, J. (1992). Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J. Bone Miner. Res. 7:987–997.
   PubMed Web of Science ®Google Scholar
• Chen, J., Thomas, H.F., Jin, H., Jiang, H., and Sodek, J. (1996). Expression of rat bone sialoprotein promoter in transgenic mice. J. Bone Miner. Res. 11:654–664.
   PubMed Web of Science ®Google Scholar
• Chen, J., Jiang, H., Sodek, J., Karsenty, G., Thomas, H., and Ranly(1999). Comparison of expression patterns of core binding factor (Osf2/Cbfa1) and bone sialoprotein (BSP). In Chemistry and Biology of Mineralized Tissue (M. Goldberg, A. Boskey, and C. Robinson), pp. 149 – 154 (American Academy of Orthopaedic Surgery, Rosemount, IL).
   Google Scholar
• Bellahcene, A., Merville, M.P., and Castronovo, V. (1994). Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res. 54:2823–2826.
   PubMed Web of Science ®Google Scholar
• Oldberg, A., Franzen, A., Heinegard, D., Pierschbacher, M., and Ruoslahti,(1988). Identification of a bone sialoprotein receptor in osteosarcoma cells. J. Biol. Chem. 263:19433–19436.
   PubMed Web of Science ®Google Scholar
• Goldberg, H.A., Warner, K.J., Stillman, M.J., and Hunter, G.K. (1996). Determination of the hydroxyapatite-nucleating region of bone sialopro- tein. Connect. Tiss. Res. 35:385–392.
   PubMed Web of Science ®Google Scholar
• Sung, V., Stubbs, J.T.R., Fisher, L., Aaron, A. D., and Thompson, E. W. (1998). Bone sialoprotein supports breast cancer cell adhesion prolifer- ation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J. Cell Physiol. 176:482–494.
   PubMed Web of Science ®Google Scholar
• Chen, J., Aufdemorte, T.B., Jiang, H., Liu, A.R., Zhang, W., and Thomas, H.F. (1998). Neoplastic odontogenic epithelial cells express bone sialoprotein. Histochem. J. 30:1–6.
   PubMedGoogle Scholar
• Bellahcene, A., Menard, S., Bufalino, R., Moreau, L., and Castronovo, V. (1996). Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int. J. Cancer 69:350–353.
   PubMed Web of Science ®Google Scholar
• Fisher, L.W., McBride, O.W., Termine, J.D., and Young, M.F. (1990). Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J. Biol. Chem. 265:2347–2351.
   PubMed Web of Science ®Google Scholar
• Albini, A., Iwamoto, Y., Kleinman, H.K., Martin, G.R., Aaronson, S. A., Kozlowski, J.M., and McEwan, R.N. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239–3245.
   PubMed Web of Science ®Google Scholar
• Yoneda, T. (1997). Arterial microvascularization and breast cancer colo- nization in bone. Histol Histopathol. 12:1145–1149.
   PubMed Web of Science ®Google Scholar
• Kim, J., Yu, W., Kovalski, K., and Ossowski, L. (1998). Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353–362.
   PubMed Web of Science ®Google Scholar
• Bellahcene, A., Antoine, N., Clausse, N., Tagliabue, E., Fisher, L.W., Kerr, J.M., Jares, P., and Castronovo, V. (1996). Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels. Lab Invest. 75:203–210.
   PubMed Web of Science ®Google Scholar
• Sharp, J.A., Sung, V., Slavin, J., Thompson, E.W., and Henderson, M. A. (1999). Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab. Invest. 79:869–877.
   PubMed Web of Science ®Google Scholar
• Ibrahim, T., Leong, I., Sanchez-Sweatman, O., Khokha, R., Sodek, J., Tenenbaum, H.C., Ganss, B., and Cheifetz, S. (2000). Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin. Exp. Metastasis 18:253–260.
   PubMed Web of Science ®Google Scholar
• Yoneda, T., Sasaki, A., Dunstan, C., Williams, P.J., Bauss, F., De Clerck, Y.A., and Mundy, G.R. (1997). Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate iban- dronate and tissue inhibitor of the matrix metalloproteinase-2. J. Clin. Invest. 99:2509–2517.
   PubMed Web of Science ®Google Scholar
• Aznavoorian, S., Murphy, A.N., Stetler Stevenson, W.G., and Liotta, L.A. (1993). Molecular aspects of tumor cell invasion and metastasis. Cancer 71:1368–1383.
   PubMed Web of Science ®Google Scholar
• Van der Pluijm, G., Vloedgraven, H.J., Ivanov, B., Robey, F.A., Grzesik, W.J., Robey, P.G., Papapoulos, S.E., and Lowik, C.W. (1996). Bone sialo- protein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res. 56:1948–1955.
   PubMed Web of Science ®Google Scholar
• Brooks, P.C., Strˆmblad, S., Klemke, R., Visscher, D., Sarkar, F.H., and Cheresh, D.A. (1995). Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin [see comments]. J. Clin. Invest. 96:1815–1822.
   PubMed Web of Science ®Google Scholar
• Brooks, P.C., Strˆmblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683–693.
   PubMed Web of Science ®Google Scholar